Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B

Clinical trial NCT01270165 · UNKNOWN

Trial details

NCT number: NCT01270165
Sponsor: Yonsei University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2010-06-01
Primary completion: 2012-05-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.